Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532096) titled 'Extended Sentinel Lymph Node Biopsy With Methylene Blue Single Tracer Post-Neoadjuvant Therapy for Node-Positive Breast Cancer' on April 8.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Xijing Hospital

Condition: Breast Cancer

Intervention: Procedure: ESLNB

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 25, 2026

Target Sample Size: 240

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07532096

Disclaimer...